✦ LIBER ✦

Adoptive Immunotherapy for Hodgkin’s Lymphoma

✍ Scribed by Alana A. Kennedy-Nasser; Catherine M. Bollard; Cliona M. Rooney

Book ID: 111835611
Publisher: Carden Jennings Publishing
Year: 2006
Tongue: English
Weight: 93 KB
Volume: 83
Category: Article
ISSN: 0925-5710
DOI: 10.1532/ijh97.06107

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

New developments in immunotherapy for no

New developments in immunotherapy for non-Hodgkin’s lymphoma

✍ John P. Leonard; Richard R. Furman; Jia Ruan; Morton Coleman 📂 Article 📅 2005 🏛 Current Science Inc. 🌐 English ⚖ 585 KB

Transfer factor immunotherapy in Hodgkin

Transfer factor immunotherapy in Hodgkin's and non-Hodgkin's lymphoma

✍ Erkki Heinonen; Pentti Gröhn; Jussi Tarkkanen; Abdel Maiche; Veli-Matti Wasenius 📂 Article 📅 1981 🏛 Springer-Verlag 🌐 English ⚖ 549 KB

Adoptive Immunotherapy for Cancer

✍ Rosenberg, Steven A. 📂 Article 📅 1990 🏛 Nature Publishing Group 🌐 English ⚖ 530 KB

BCG in the immunotherapy of Hodgkin's di

BCG in the immunotherapy of Hodgkin's disease and non-Hodgkin's lymphomas

✍ B. Hœrni; J. Chauvergne; G. Hœrni-Simon; M. Durand; R. Brunet; C. Lagarde 📂 Article 📅 1976 🏛 Springer-Verlag 🌐 English ⚖ 232 KB

Personalized immunotherapy for the treat

Personalized immunotherapy for the treatment of non-Hodgkin's lymphoma: a promising approach

✍ Julie M Vose 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB

The efficacy of immunotherapeutic strategies for the treatment of lymphoid malignancies has been demonstrated in recent years. In patients with B-cell lymphomas, particularly indolent lymphoma, the use of passive immunotherapy, such as the anti-CD20 monoclonal antibody rituximab, has made an impress

Hodgkin's lymphoma

✍ Virendra S. Saxena; Pramilla Sarin; Frank R. Hendrickson 📂 Article 📅 1977 🏛 Elsevier Science 🌐 English ⚖ 155 KB